143 related articles for article (PubMed ID: 38491119)
21. Use of target controlled infusion to derive age and gender covariates for propofol clearance.
White M; Kenny GN; Schraag S
Clin Pharmacokinet; 2008; 47(2):119-27. PubMed ID: 18193918
[TBL] [Abstract][Full Text] [Related]
22. A manual propofol infusion regimen for neonates and infants.
Morse J; Hannam JA; Cortinez LI; Allegaert K; Anderson BJ
Paediatr Anaesth; 2019 Sep; 29(9):907-914. PubMed ID: 31325395
[TBL] [Abstract][Full Text] [Related]
23. Predictive performance of a new pharmacokinetic model for propofol in underweight patients during target-controlled infusion.
Yi JM; Doh I; Lee SH; Kim SY; Lee YH; Lee EK; Lee SH; Choi BM; Noh GJ
Acta Anaesthesiol Scand; 2019 Apr; 63(4):448-454. PubMed ID: 30690713
[TBL] [Abstract][Full Text] [Related]
24. Propofol and remifentanil effect-site concentrations estimated by pharmacokinetic simulation and bispectral index monitoring during craniotomy with intraoperative awakening for brain tumor resection.
Lobo F; Beiras A
J Neurosurg Anesthesiol; 2007 Jul; 19(3):183-9. PubMed ID: 17592350
[TBL] [Abstract][Full Text] [Related]
25. [Pharmacokinetic evaluation of a computerized target-controlled infusion system: application to propofol in orthopedic surgery].
Aouizerate P; Dumé L; Bouleau D; Duvaldestin P; Astier A
Therapie; 1998; 53(6):543-51. PubMed ID: 10070231
[TBL] [Abstract][Full Text] [Related]
26. The effects of plasma fentanyl concentrations on propofol requirement, emergence from anesthesia, and postoperative analgesia in propofol-nitrous oxide anesthesia.
Han T; Kim D; Kil H; Inagaki Y
Anesth Analg; 2000 Jun; 90(6):1365-71. PubMed ID: 10825322
[TBL] [Abstract][Full Text] [Related]
27. The performance of compartmental and physiologically based recirculatory pharmacokinetic models for propofol: a comparison using bolus, continuous, and target-controlled infusion data.
Masui K; Upton RN; Doufas AG; Coetzee JF; Kazama T; Mortier EP; Struys MM
Anesth Analg; 2010 Aug; 111(2):368-79. PubMed ID: 19861357
[TBL] [Abstract][Full Text] [Related]
28. Non-steady state analysis of the pharmacokinetic interaction between propofol and remifentanil.
Bouillon T; Bruhn J; Radu-Radulescu L; Bertaccini E; Park S; Shafer S
Anesthesiology; 2002 Dec; 97(6):1350-62. PubMed ID: 12459659
[TBL] [Abstract][Full Text] [Related]
29. Propofol Breath Monitoring as a Potential Tool to Improve the Prediction of Intraoperative Plasma Concentrations.
Colin P; Eleveld DJ; van den Berg JP; Vereecke HEM; Struys MMRF; Schelling G; Apfel CC; Hornuss C
Clin Pharmacokinet; 2016 Jul; 55(7):849-859. PubMed ID: 26715214
[TBL] [Abstract][Full Text] [Related]
30. Prospective clinical validation of the Eleveld propofol pharmacokinetic-pharmacodynamic model in general anaesthesia.
Vellinga R; Hannivoort LN; Introna M; Touw DJ; Absalom AR; Eleveld DJ; Struys MMRF
Br J Anaesth; 2021 Feb; 126(2):386-394. PubMed ID: 33317804
[TBL] [Abstract][Full Text] [Related]
31. [Effect of ear point embedding on plasma and effect site concentrations of propofol-remifentanil in elderly patients after target-controlled induction].
Zheng X; Wan L; Gao F; Chen J; Tu W
Zhongguo Zhen Jiu; 2017 Aug; 37(8):869-873. PubMed ID: 29231349
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of propofol administered by target-controlled infusion to alcoholic patients.
Servin FS; Bougeois B; Gomeni R; Mentré F; Farinotti R; Desmonts JM
Anesthesiology; 2003 Sep; 99(3):576-85. PubMed ID: 12960541
[TBL] [Abstract][Full Text] [Related]
33. Evaluation and optimisation of propofol pharmacokinetic parameters in cats for target-controlled infusion.
Cattai A; Pilla T; Cagnardi P; Zonca A; Franci P
Vet Rec; 2016 May; 178(20):503. PubMed ID: 27044652
[TBL] [Abstract][Full Text] [Related]
34. Mixed-effects modeling of the influence of midazolam on propofol pharmacokinetics.
Vuyk J; Lichtenbelt BJ; Olofsen E; van Kleef JW; Dahan A
Anesth Analg; 2009 May; 108(5):1522-30. PubMed ID: 19372331
[TBL] [Abstract][Full Text] [Related]
35. Influence of administration rate on propofol plasma-effect site equilibration.
Struys MM; Coppens MJ; De Neve N; Mortier EP; Doufas AG; Van Bocxlaer JF; Shafer SL
Anesthesiology; 2007 Sep; 107(3):386-96. PubMed ID: 17721240
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetic Analysis of Propofol Target-Controlled Infusion Models in Chinese Patients with Hepatic Insufficiency.
Chi X; Pan J; Cai J; Luo G; Li S; Yuan D; Rui J; Chen W; Hei Z
Med Sci Monit; 2018 Sep; 24():6925-6933. PubMed ID: 30269150
[TBL] [Abstract][Full Text] [Related]
37. Development and validation of brain target controlled infusion of propofol in mice.
Shortal BP; Reitz SL; Aggarwal A; Meng QC; McKinstry-Wu AR; Kelz MB; Proekt A
PLoS One; 2018; 13(4):e0194949. PubMed ID: 29684039
[TBL] [Abstract][Full Text] [Related]
38. Clinical adaptation of a pharmacokinetic model of Propofol plasma concentrations in children.
Engelhardt T; McCheyne AJ; Morton N; Karsli C; Luginbuehl I; Adeli K; Walsh W; Bissonnette B
Paediatr Anaesth; 2008 Mar; 18(3):235-9. PubMed ID: 18179618
[TBL] [Abstract][Full Text] [Related]
39. [Population pharmacokinetic modeling and evaluation of propofol from multiple centers].
Ye HB; Zheng H; Zhang XA; Chi XJ; Chen WY; Xu JG; Li JH; Rui JZ
Yao Xue Xue Bao; 2010 Dec; 45(12):1550-8. PubMed ID: 21351496
[TBL] [Abstract][Full Text] [Related]
40. Ketofol simulations for dosing in pediatric anesthesia.
Coulter FL; Hannam JA; Anderson BJ
Paediatr Anaesth; 2014 Aug; 24(8):806-12. PubMed ID: 24666723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
